
Company Info
Year Established2009
Ticker
KOD
Exchange
NASDAQ
Contacts
Victor Perlroth, M.D.Chair & CEO
John Borgeson
CFO
Michael S. Louie, Ph.D.
CIO
Company Description
Kodiak a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence ophthalmic diseases